A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

NCT00241449 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Metastasis

Interventions

DRUG: Fulvestrant
DRUG: Tamoxifen

Sponsor

AstraZeneca